英文名称 |
中文名称 |
CAS号 |
操作 |
Sofosbuvir Impurity 15 |
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷酰基]-L-丙氨酸异丙酯 |
1334513-02-8 |
详细
|
Sofosbuvir Impurity 21 |
索非布韦杂质21 |
1496552-50-1 |
详细
|
Sofosbuvir Impurity 37 ( Sofosbuvir Isomer) |
索非布韦对映异构体 |
|
详细
|
Sofosbuvir Impurity 32 |
(2S)-3,5-二-O-苯甲酰基-2-氟-2-C-甲基-D-核糖酸-C-内酯 |
1157884-58-6 |
详细
|
Sofosbuvir Impurity 36 |
索非布韦杂质36 |
|
详细
|
Pramipexole Impurity 4 |
普拉克索杂质4 |
|
详细
|
Sofosbuvir Impurity 33 |
((2R,3R,4R)-3-(苯甲酰氧基)-4-氯-4-甲基-5-氧代四氢呋喃-2-基)甲基苯甲酸甲酯 |
1496551-65-5 |
详细
|
Sodium Phenylbutyrate |
4-苯基丁酸钠盐 |
1716-12-7 |
详细
|
Sofosbuvir Impurity 31 |
1015073-42-3 |
1015073-42-3 |
详细
|
Pramipexole Impurity 27 |
普拉克索杂质27 |
2744063-34-9 |
详细
|
Pramipexole Impurity 20 |
(R)-N-(2-氨基-4,5,6,7-四氢苯并噻唑-6-基)-丙酰胺 |
106006-85-3 |
详细
|
Pramipexole Impurity 44 |
|
|
详细
|
2, 6-Diamino-5 ,6-Dihydrobenzo[d]thiazol-7(4H)-One |
普拉克索杂质 |
1391053-80-7 |
详细
|
Solifenacin Related Compound 2 Succinate |
索非那新琥珀酸相关物质2 |
1262506-09-1 |
详细
|
Sofosbuvir Impurity 26 |
索非布韦杂质26 |
|
详细
|
Sofosbuvir Impurity 25 |
索非布韦杂质25 |
|
详细
|
Sofosbuvir Impurity 40 |
索非布韦杂质40 |
|
详细
|
Sofosbuvir Impurity 22 (GS-491241) |
|
|
详细
|
Sofosbuvir Impurity 17 |
索非布韦杂质17 |
|
详细
|
Sofosbuvir Impurity 3 |
|
|
详细
|
Sofosbuvir Impurity 14 |
索非布韦杂质14 |
|
详细
|
Sofosbuvir Impurity 24 |
索非布韦杂质24 |
|
详细
|
Sofosbuvir Impurity 38 |
索非布韦杂质38 |
|
详细
|
Sofosbuvir Impurity 43 |
索非布韦杂质43 |
|
详细
|
Sofosbuvir Impurity 6 |
索非布韦杂质6 |
|
详细
|
Sofosbuvir Impurity 10 |
|
1910099-17-0 |
详细
|
Sofosbuvir Impurity 27 |
索非布韦杂质27 |
|
详细
|
Sofosbuvir Impurity 42 |
索非布韦杂质42 |
|
详细
|
Sofosbuvir Impurity 28 |
索非布韦杂质28 |
|
详细
|
Sofosbuvir Impurity 16 |
|
|
详细
|
1-Phenyl-3,4-dihydroisoquinoline |
1-苯基-3,4-二氢异喹啉 |
52250-50-7 |
详细
|
Solifenacin N-Oxide |
索利那新N-氧化物 |
180272-28-0 |
详细
|
Solifenacin Impurity 1 |
盐酸溴己新杂质1 |
1243274-81-8 |
详细
|
Sofosbuvir Impurity 5 |
|
|
详细
|
Pramipexole Impurity 56 |
|
|
详细
|
Solifenacin Related Compound 4 Succinate |
索非那新琥珀酸相关物质4 |
862207-71-4 |
详细
|
Pramipexole Impurity 5 |
普拉克索杂质5 |
|
详细
|
Pramipexole Impurity 2 |
普拉克索杂质2 |
104617-75-6 |
详细
|
4-Hydroxy Solifenacin (trans, Mixture of (1R,4R) and (1S,4S) Diastereomers) |
|
|
详细
|
Solifenacin Related Compound 9 |
(R)-1-苯基-1,2,3,4-四氢异喹啉 |
180272-45-1 |
详细
|
Solifenacin Related Compound 3 Succinate |
索非那新琥珀酸相关物质3 |
862207-70-3 |
详细
|
Pramipexole Impurity 52 |
普拉克索杂质 |
1254579-15-1 |
详细
|
Pramipexole Impurity 54 |
6-乙酰胺基-2-氨基-4,5,6,7-四氢苯并噻唑 |
104617-51-8 |
详细
|
Pramipexole Impurity 48 |
外消旋N-丙基-2-氰基亚胺基吡咯烷-5-乙酸 |
1246833-75-9 |
详细
|
Pramipexole Impurity 50 |
R-盐酸普拉克索 |
908244-04-2 |
详细
|
Solifenacin EP Impurity B |
索利那新杂质 1 |
1353274-25-5 |
详细
|
Solifenacin Impurity (4-Nitrophenyl (1S)-1-Phenyl-3-4-Dihidroisoquinoline-2(1H)-Carboxylate) |
索利那新杂质2 |
1229227-22-8 |
详细
|
Solifenacin Related Compound 29 |
索利那新杂质29 |
861998-77-8 |
详细
|
Sofosbuvir Impurity 7 |
|
|
详细
|
4-Hydroxy Solifenacin N-Oxide (trans, Mixture of (1R,4R) and (1S,4S) Diastereomers) |
|
|
详细
|
2-Amino-6-Bromo-5 ,6-Dihydrobenzo[d]thiazol-7(4H)-One |
2-氨基-6-溴-7-氧代-4,5,6,7-四氢苯并噻唑 |
1001648-73-2 |
详细
|
Pramipexole Impurity 6 |
普拉克索杂质6 |
|
详细
|
(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
(S)-1-苯基-1,2,3,4-四氢异喹啉 |
118864-75-8 |
详细
|
Pramipexole Dimer Impurity (Mixture of Diastereomers) |
普拉克索二聚物杂质(非对映体混合物) |
|
详细
|
Solifenacin Related Compound 33 |
索利那新杂质 |
1956436-64-8 |
详细
|
Pramipexole Related Impurity 4 |
普拉克索相关杂质4 |
|
详细
|
Pramipexole Impurity 12 |
普拉克索杂质12 |
|
详细
|
Solifenacin Related Compound 8 |
(S)-1-苯基-1,2,3,4-四氢-2-异喹啉甲酸乙酯 |
180468-42-2 |
详细
|
Sofosbuvir Impurity 8 |
索非布韦杂质8 |
944476-44-2 |
详细
|
Solifenacin Related Compound 14 |
索利那新杂质14 |
605696-10-4 |
详细
|
Solifenacin EP Impurity D |
索利那新杂质D |
|
详细
|
Solifenacin Related Compound 13 |
Solifenacin Related Compound 13 |
1251905-45-9 |
详细
|
Pramipexole Formaldehyde Adduct Impurity |
普拉克索甲醛加合物杂质 |
|
详细
|
Pramipexole Impurity 17 |
普拉克索杂质17 |
|
详细
|
Pramipexole Impurity 25 |
普拉克索杂质25 |
|
详细
|
Pramipexole Impurity 18 |
普拉克索杂质18 |
|
详细
|
Pramipexole Impurity V |
(6S)-2-氨基-6-丙酰氨基四氢苯并噻唑 |
106006-84-2 |
详细
|
Pramipexole Impurity 30 |
普拉克索杂质30 |
|
详细
|
Pramipexole Related Impurity 1 |
普拉克索相关杂质1 |
|
详细
|
Pramipexole Impurity 15 |
普拉克索杂质15 |
|
详细
|
Pramipexole Impurity 33 |
2-氨基-6-甲砜基苯并噻唑 |
17557-67-4 |
详细
|
N-Carbobenyloxy Pramipexole |
N-CARBOBENYLOXY PRAMIPEXOLE |
|
详细
|
Solifenacin Related Compound 7 |
索利那新USP杂质7 |
|
详细
|
Pramipexole Related Impurity 2 |
普拉克索相关杂质2 |
|
详细
|
Pramipexole Impurity 1 |
Pramipexole DBTA Impurity |
1821389-09-6 |
详细
|
Pramipexole Impurity 45 |
3,4-二甲氧基苯磺酰胺 |
4570-41-6 |
详细
|
Pramipexole Impurity 42 |
2,6-二氨基-4,5,6,7-四氢苯并噻唑 |
106006-83-1 |
详细
|
Pramipexole Impurity 35 |
普拉克索杂质35 |
1867177-06-7 |
详细
|
Solifenacin Related Compound 15 |
索利那新杂质15 |
|
详细
|
Solifenacin N-Glucuronide |
索利那新N-葡糖苷酸 |
|
详细
|
Pramipexole Impurity 47 |
顺式消旋-7-羟基普拉克索 |
1001648-71-0 |
详细
|
Pramipexole Impurity 29 |
(S)-4,5,6,7-四氢-N2,N6-丙酰基-2,6-苯并噻唑二胺 |
1346617-47-7 |
详细
|
Pramipexole Dimer Impurity II |
PraMipexole DiMer IMpurity II |
2206826-82-4 |
详细
|
Pramipexole Impurity 22 |
普拉克索杂质22 |
|
详细
|
Pramipexole Impurity 32 |
|
|
详细
|
Pramipexole Related Impurity 3 |
普拉克索相关杂质3 |
|
详细
|
Pramipexole Impurity 21 |
普拉克索杂质21 |
|
详细
|
Pramipexole Impurity 41 |
|
|
详细
|
Pramipexole Impurity 31 |
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
详细
|
Pramipexole Impurity 19 |
普拉克索杂质19 |
|
详细
|
Solifenacin Related Compound 16 |
索利那新相关化合物16 |
|
详细
|
Pramipexole Impurity 46 |
2-氨基苯并噻唑 |
136-95-8 |
详细
|
Solifenacin |
索非那新 |
242478-37-1 |
详细
|
Pramipexole Impurity D |
普拉克索杂质D |
104632-27-1 |
详细
|
Solifenacin Related Compound 5 |
索利那新相关物质5 |
|
详细
|
Pramipexole Impurity 16 |
普拉克索杂质16 |
1373869-91-0 |
详细
|
Pramipexole Impurity 51 |
普拉克索杂质 15 |
1965329-42-3 |
详细
|
Pramipexole Impurity 24 |
普拉克索杂质24 |
|
详细
|
Pramipexole Impurity 36 |
普拉克索杂质36 |
|
详细
|
Pramipexole Impurity 14 |
普拉克索杂质14 |
|
详细
|